These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 16339533)

  • 1. The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+/CD25+ T-regulatory cells and enhances their functional activity.
    Sawicka E; Dubois G; Jarai G; Edwards M; Thomas M; Nicholls A; Albert R; Newson C; Brinkmann V; Walker C
    J Immunol; 2005 Dec; 175(12):7973-80. PubMed ID: 16339533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine-1-phosphate receptor agonism impairs the efficiency of the local immune response by altering trafficking of naive and antigen-activated CD4+ T cells.
    Xie JH; Nomura N; Koprak SL; Quackenbush EJ; Forrest MJ; Rosen H
    J Immunol; 2003 Apr; 170(7):3662-70. PubMed ID: 12646631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sphingosine-1-phosphate receptor agonist FTY720 and its phosphorylated form affect the function of CD4+CD25+ T cells in vitro.
    Liu Y; Jiang J; Xiao H; Wang X; Li Y; Gong Y; Huang Y
    Int J Mol Med; 2012 Jul; 30(1):211-9. PubMed ID: 22576630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells.
    Daniel C; Sartory N; Zahn N; Geisslinger G; Radeke HH; Stein JM
    J Immunol; 2007 Feb; 178(4):2458-68. PubMed ID: 17277153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R⁻/⁻) mice.
    Poti F; Costa S; Bergonzini V; Galletti M; Pignatti E; Weber C; Simoni M; Nofer JR
    Vascul Pharmacol; 2012 Aug; 57(1):56-64. PubMed ID: 22459073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The S1P-analog FTY720 differentially modulates T-cell homing via HEV: T-cell-expressed S1P1 amplifies integrin activation in peripheral lymph nodes but not in Peyer patches.
    Halin C; Scimone ML; Bonasio R; Gauguet JM; Mempel TR; Quackenbush E; Proia RL; Mandala S; von Andrian UH
    Blood; 2005 Aug; 106(4):1314-22. PubMed ID: 15870184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sphingosine 1-phosphate receptor agonist FTY720 potently inhibits regulatory T cell proliferation in vitro and in vivo.
    Wolf AM; Eller K; Zeiser R; Dürr C; Gerlach UV; Sixt M; Markut L; Gastl G; Rosenkranz AR; Wolf D
    J Immunol; 2009 Sep; 183(6):3751-60. PubMed ID: 19692647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive drugs on inducing Ag-specific CD4(+)CD25(+)Foxp3(+) Treg cells during immune response in vivo.
    Wu T; Zhang L; Xu K; Sun C; Lei T; Peng J; Liu G; Wang R; Zhao Y
    Transpl Immunol; 2012 Aug; 27(1):30-8. PubMed ID: 22613676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
    Maeda Y; Seki N; Sato N; Sugahara K; Chiba K
    Int Immunol; 2010 Jun; 22(6):515-25. PubMed ID: 20497959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
    Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
    Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory drug FTY720 induces regulatory CD4(+)CD25(+) T cells in vitro.
    Zhou PJ; Wang H; Shi GH; Wang XH; Shen ZJ; Xu D
    Clin Exp Immunol; 2009 Jul; 157(1):40-7. PubMed ID: 19659769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
    Chiba K
    Pharmacol Ther; 2005 Dec; 108(3):308-19. PubMed ID: 15951022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting S1P1 receptor protects against murine immunological hepatic injury through myeloid-derived suppressor cells.
    Liu G; Bi Y; Wang R; Yang H; Zhang Y; Wang X; Liu H; Lu Y; Zhang Z; Chen W; Chu Y; Yang R
    J Immunol; 2014 Apr; 192(7):3068-79. PubMed ID: 24567529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTY720 stimulates multidrug transporter- and cysteinyl leukotriene-dependent T cell chemotaxis to lymph nodes.
    Honig SM; Fu S; Mao X; Yopp A; Gunn MD; Randolph GJ; Bromberg JS
    J Clin Invest; 2003 Mar; 111(5):627-37. PubMed ID: 12618517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory effects of FTY720 against viral-induced immunopathology: role of drug-induced conversion of T cells to become Foxp3+ regulators.
    Sehrawat S; Rouse BT
    J Immunol; 2008 Jun; 180(11):7636-47. PubMed ID: 18490766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: Alternative signaling of Th17 cell development by sphingosine 1-phosphate.
    Liao JJ; Huang MC; Goetzl EJ
    J Immunol; 2007 May; 178(9):5425-8. PubMed ID: 17442922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway.
    Ntranos A; Hall O; Robinson DP; Grishkan IV; Schott JT; Tosi DM; Klein SL; Calabresi PA; Gocke AR
    J Neuroimmunol; 2014 May; 270(1-2):13-21. PubMed ID: 24680062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FTY720-induced conversion of conventional Foxp3- CD4+ T cells to Foxp3+ regulatory T cells in NOD mice.
    Sun Y; Wang W; Shan B; Di J; Chen L; Ren L; Li W; Li DJ; Lin Y
    Am J Reprod Immunol; 2011 Nov; 66(5):349-62. PubMed ID: 21623989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sphingosine-1-phosphate receptor agonist FTY720 modulates dendritic cell trafficking in vivo.
    Lan YY; De Creus A; Colvin BL; Abe M; Brinkmann V; Coates PT; Thomson AW
    Am J Transplant; 2005 Nov; 5(11):2649-59. PubMed ID: 16212624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of experimental autoimmune uveitis in mice treated with FTY720.
    Commodaro AG; Peron JP; Lopes CT; Arslanian C; Belfort R; Rizzo LV; Bueno V
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2568-74. PubMed ID: 20019358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.